Mallinckrodt will acquire Questcor for approximately $5.6 Billion, creating a diversified, high-growth specialty pharmaceuticals company.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.
